UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000022826
Receipt No. R000026259
Official scientific title of the study Supplemental effect of fermented soy product on rush oral immunotherapy (F-SOI)- Double blind - randomized placebo control trial -
Date of disclosure of the study information 2016/06/21
Last modified on 2018/06/29 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Supplemental effect of fermented soy product on rush oral immunotherapy (F-SOI)- Double blind - randomized placebo control trial -
Title of the study (Brief title) F-SOI
Region
Japan

Condition
Condition food allergy
Classification by specialty
Clinical immunology Pediatrics Child
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy of combined therapy comprising fermanted soy product with rush oral immunotherapy.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The total score of allergic reaction score plus rescue drug score during rash phase of OIT.
Key secondary outcomes The amount of food consumption and the proportion of patients who reached the target dose (20g of boiled egg, 100ml of milk and 100g of udon noodle) at discharge and at 3 months after discharge.
The changes in value of laboratory data (e.g. specific IgE titer)
The changes in value of the threshold dose of antigen and severity of allergic reaction provoked in OFCs

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Double blind -all involved are blinded
Control Placebo
Stratification YES
Dynamic allocation
Institution consideration
Blocking YES
Concealment Numbered container method

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 the consumption of 600mg/day fermanted soy product from 1~2 month before ROIT to 3 months after the end of rash phase of OIT
Interventions/Control_2 the consumption of plasebo from 1~2 month before starting ROIT until 3 month after the end of rash phase of OIT
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
5 years-old <
Age-upper limit
18 years-old >=
Gender Male and Female
Key inclusion criteria patient with severe food allergy for egg, milk, wheat diagnosed by oral food challenge
Key exclusion criteria patients with severe comorbidity
patients with uncontrollable asthma or atopic dermatitis
patients with severe food allergy for soybeans
patients whom the doctor assess ineligible
Target sample size 55

Research contact person
Name of lead principal investigator Komei Ito
Organization Aichi Children's Health and Medical Center
Division name Department of Allergy
Address 7-426, Morioka, Obu, Aichi 474-8710, Japan
TEL 0562-43-0500
Email koumei_itoh@mx.achmc.pref.aichi.jp

Public contact
Name of contact person Iwao Tajima
Organization Aichi Children's Health and Medical Center
Division name Department of Allergy
Address 7-426, Morioka, Obu, Aichi 474-8710, Japan
TEL 0562-43-0500
Homepage URL
Email iwao_tajima@sk00106.achmc.pref.aichi.jp

Sponsor
Institute Aichi Children's Health and Medical Center
Institute
Department

Funding Source
Organization NICHIMO BIOTICS Co.,Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions あいち小児保健医療総合センター(愛知県)

Other administrative information
Date of disclosure of the study information
2016 Year 06 Month 21 Day

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 03 Month 11 Day
Anticipated trial start date
2016 Year 05 Month 21 Day
Last follow-up date
2018 Year 06 Month 30 Day
Date of closure to data entry
2018 Year 06 Month 30 Day
Date trial data considered complete
2018 Year 08 Month 31 Day
Date analysis concluded
2018 Year 12 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 06 Month 21 Day
Last modified on
2018 Year 06 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000026259